Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.74 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.74 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.64 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.64 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.64 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.64 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.64 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.64 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.64 |
| ▸ | HTR2A | P28223 | 1/20 | 0.64 |
| ▸ | HTR2C | P28335 | 1/20 | 0.64 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.64 |
| ▸ | HRH1 | P35367 | 1/20 | 0.64 |
| ▸ | DRD3 | P35462 | 1/20 | 0.64 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.64 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.64 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.61 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL538817 | 0.98 | CA2 (0.71) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL1310131 | 0.98 | CA2 (0.71) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL1457282 | 0.98 | CA2 (0.71) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL5683424 | 0.98 | CA2 (0.71) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL9118821 | 0.98 | CA2 (0.71) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL112564 | 0.98 | CA2 (0.71) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL2492298 | 0.98 | CA2 (0.71) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL112082 | 0.98 | CA2 (0.71) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL2836840 | 0.98 | CA2 (0.71) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL160269 | 0.98 | CA2 (0.71) | CA2MAPK1GRIK1GRIK2SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 222 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101679908-B | Organic compounds | GIVAUDAN SA | 2012-10-24 | — | — | CN | claimed |
| CN-102459278-A | Substituted-1, 3, 8-triazaspiro [4.5] decane-2, 4-diones | MERCK SHARP & DOHME | 2012-05-16 | — | — | CN | claimed |
| EP-1716159-B1 | BICYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | MOMENTIVE PERFORMANCE MAT INC (US) | 2011-07-13 | — | — | EP | claimed |
| CN-101679908-A | organic compounds | GIVAUDAN SA | 2010-03-24 | — | — | CN | claimed |
| EP-1697386-B1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GEN ELECTRIC (US) | 2007-10-10 | — | — | EP | claimed |
| EP-1328161-B1 | AMBIENT STABLE BEVERAGE | UNILEVER PLC (GB) | 2007-04-18 | — | — | EP | claimed |
| EP-1282368-B1 | AMBIENT STABLE BEVERAGE | UNILEVER PLC (GB) | 2005-07-27 | — | — | EP | claimed |
| US-20260137803-A1 | LIPID NANOPARTICLES AND METHODS OF MANUFACTURE AND USE THEREOF | GENZYME CORP (US) | 2026-05-21 | — | — | US | disclosed |
| US-12564879-B2 | Copper paste for joining, method for manufacturing joined body, and joined body | RESONAC CORPORATION (JP) | 2026-03-03 | — | — | US | disclosed |
| US-20260028721-A1 | METHOD FOR MANUFACTURING SUBSTRATE WITH CONDUCTIVE VIAS AND METHOD FOR MANUFACTURING WIRING BOARD WITH CONDUCTIVE VIAS | RESONAC CORP (JP) | 2026-01-29 | — | — | US | disclosed |
| US-20250387833-A1 | METHOD FOR MANUFACTURING CONDUCTIVE VIA-CONTAINING SUBSTRATE, CONDUCTIVE VIA-CONTAINING SUBSTRATE, AND METAL PASTE | RESONAC CORP (JP) | 2025-12-25 | — | — | US | disclosed |
| EP-4658313-A1 | HSC-SPECIFIC ANTIBODY CONJUGATED LIPID NANOPARTICLES AND USES THEREOF | GENZYME CORPORATION (US) | 2025-12-10 | — | — | EP | disclosed |
| US-20250293091-A1 | METHOD FOR PRODUCING SUBSTRATE HAVING THROUGH-SILICON VIAS, SUBSTRATE HAVING THROUGH-SILICON VIAS, AND COPPER PASTE FOR THROUGH-SILICON VIA FORMATION | RESONAC CORPORATION (JP) | 2025-09-18 | — | — | US | disclosed |
| WO-1995018616-A2 | 8-AZA, 6-AZA AND 6,8-DIAZA-1,4-DIHYDROQUINOXALINE-2,3-DIONES AND THE USE THEREOF AS ANTAGONISTS FOR THE GLYCINE/NMDA RECEPTOR | ACEA PHARM INC (US) | 1995-07-13 | — | — | WO | disclosed |
| EP-0647137-A1 | GLYCINE RECEPTOR ANTAGONISTS AND THE USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-04-12 | — | — | EP | disclosed |
| WO-1994000124-A1 | GLYCINE RECEPTOR ANTAGONISTS AND THE USE THEREOF | WEBER ECKARD (US) | 1994-01-06 | — | — | WO | disclosed |
| US-5252432-A | Developing the recoding layer with developer 3-methoxy-butyl acetate or/and butyl glycolate | BASF AKTIENGESELLSCHAFT (DE) | 1993-10-12 | — | — | US | disclosed |
| US-5240815-A | Exposing photopolymerizable component to actinic light, development | BASF AKTIENGESELLSCHAFT (DE) | 1993-08-31 | — | — | US | disclosed |
| US-5128234-A | PRODUCTION OF PHOTOPOLYMERIC FLEXOGRAPHIC RELIEF PRINTING PLATES | BASF AKTIENGESELLSCHAFT (DE) | 1992-07-07 | — | — | US | disclosed |
| US-5080889-A | Oil, oxidation resistance, stability | KAO CORPORATION (JP) | 1992-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250387833-A1 | METHOD FOR MANUFACTURING CONDUCTIVE VIA-CONTAINING SUBSTRATE, CONDUCTIVE VIA-CONTAINING SUBSTRATE, AND METAL PASTE | C5, C9, CUTA | CA2 2282/4885MAPK1 210/4885GRIK1 1331/4885 |
| US-20260028721-A1 | METHOD FOR MANUFACTURING SUBSTRATE WITH CONDUCTIVE VIAS AND METHOD FOR MANUFACTURING WIRING BOARD WITH CONDUCTIVE VIAS | PIEZO1, CACNA1C, GJB2 | CA2 1511/4885MAPK1 86/4885GRIK1 812/4885 |
| US-12564879-B2 | Copper paste for joining, method for manufacturing joined body, and joined body | DCX, DNAJA2, DNAJA1 | CA2 4461/4885MAPK1 3048/4885GRIK1 2953/4885 |
| US-20260137803-A1 | LIPID NANOPARTICLES AND METHODS OF MANUFACTURE AND USE THEREOF | CD2BP2, CD2, CD4 | CA2 1782/4885MAPK1 3564/4885GRIK1 4454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.